About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Cognitive Dysfunction in MDD Patients | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNPhase 4NCT03187093

Cognitive Dysfunction in MDD Patients

Major Depressive Disorder (MDD) is one of the most prevalent mental diagnosis within the worldwide population. Although there is evidence about relationship between MDD and cognitive dysfunction, stil...

Lead sponsor: Oleg Levada•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Oleg A. Levada, MD, ScD

CONTACT

+380672623972 olevada@zmapo.edu.ua

Alexandra Troyan

CONTACT

+380673287519 troian@zmapo.edu.ua

Sponsors

Lead Sponsor

Oleg Levada

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Outpatient 18 to 65 years of age
•Meets DSM-5 criteria for MDD
•Depressive episode duration ≥ 2 months
•The participant has MARDS total score ≥ 7
•Free of psychotropic medications for at least 5 half-lives before baseline
•Fluent in Russian/Ukrainian

Exclusion Criteria

•Current diagnosis or history of manic/hypomanic episode
•Any other psychiatric diagnosis that is considered the primary diagnosis
•Any significant personality disorder diagnosis
•High suicidal risk, defined by clinician judgment
•Substance dependence/abuse in the past year
•Significant neurological disorders, head trauma, or other unstable medical conditions
•History of endocrinological diseases
•Pregnant or breastfeeding
•Psychosis in the current episode
•High risk for hypomanic switch
•Cognitive or language impairment of such severity as to adversely affect the performance of tests

Related studies

RECRUITINGPhase 3

A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)

NCT07592689 · Major Depressive Disorder

RECRUITINGPhase 2

Efficacy and Safety of Sertraline Combined With Lactobacillus Crispatus in Adolescents With Depression

NCT07539805 · Major Depressive Disorder (MDD), Probiotic Intervention

RECRUITINGPhase 2

Sertraline Combined With Multi-Strain Probiotics for Adolescent Depression

NCT07645157 · Major Depressive Disorder (MDD), Probiotic Intervention

Analgesic Efficacy of Multisite rTMS in Fibromyalgia Patients

NCT07642882 · Fibromyalgia, Depression - Major Depressive Disorder, and more

RECRUITINGPhase 3

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

NCT07076407 · Major Depressive Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 10, 2019Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment150

Start dateOct 2016

Last updatedJan 10, 2019

Condition

Major Depressive Disorder

Locations shown

State Institution "Zaporizhzhia Medical Academy of Postgraduate Education Ministry of Health of Ukraine"

Zaporizhzhia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 10, 2019Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions